Covered Call Analyzer AGGRESSIVE "STOCKS-TO-CONSIDER"
for August, 2003
|
Company Name |
Stock Symbol |
Stock Price |
# of shares |
Total Cost* |
Option Symbol |
Sep Option Price |
Income from sale* |
Strike Price |
Projected return if Called after one month* |
Actual $ return* |
Actual % Return* |
Apogee Enterprises | APOG | $10.35 | 900 | $9,335 | EQGIV | $0.90 | $790 | 12.5 | 28% | +$1,895 | 20% |
| Comments: |
We did not have the proper symbol for the option. It should have been QJAIV which did not have a bid price of 0.90. Therefore the contracts were not sold but the shares were held to expiration and sold at $12.70 for a nice profit. |
||||||||||
| Protein Design Labs | PDLI | $11.88 | 900 | $9,812 | PQIIV | $0.65 | $565 | 12.55 | 20% | +$976 | +10% |
| Comments: |
Called. |
||||||||||
| Alexion Pharm. | ALXN | $13.61 | 700 | $9,547 | XQNIC | $0.55 | $365 | 15 | 13% | +$1,318 | +14% |
| Comments: |
Called. |
||||||||||
| Boston Comm. Group | BCGI | $11.75 | 800 | $9,420 | QGBIV | $0.80 | $620 | 12.5 | 12% | ($612) | -6% |
| Comments: |
Not called. Sold the Oct12.5 at 0.50. Exercised get-out price at $9.99 after buying back calls at 0.23. |
||||||||||
| CV Therapeutics | CVTX | $23.44 | 400 | $9,396 | UXCIE | $1.50 | $580 | 25 | 12% | +$1,184 | +13% |
| Comments: |
Called. |
||||||||||
| NVIDIA Corp. | NVDA | $16.13 | 600 | $9,698 | UVAIW | $0.60 | $340 | 17.50 | 11% | +$1,142 | +12% |
| Comments: |
Called. |
||||||||||
| ICOS Corp. | ICOS | $32.81 | 300 | $9,863 | IIQIG | $1.35 | $385 | 35 | 10% | +$1,022 | +10% |
| Comments: |
Called. |
||||||||||
| Broadcom, Inc. | BRCM | $21.25 | 400 | $8,520 | RCQIX | $0.85 | $320 | 22.5 | 9% | +$800 | +9% |
| Comments: |
Called. |
||||||||||
| Andrx Corporation | ADRX | $17.06 | 500 | $8,505 | QAXIW | $1.05 | $505 | 17.5 | 8% | +$705 | +8% |
| Comments: |
Called. |
||||||||||
| Take-Two Interactive Software | TTWO | $26.53 | 300 | $7,979 | TUOIY | $1.10 | $310 | 27.5 | 7% | +$581 | +7% |
| Comments: |
Called. |
||||||||||
|
All positions closed out with portfolio value up +$9,012. |
|||||||||||
The stocks listed above are for illustrative and educational purposes only and should not be construed as an endorsement, recommendation, or solicitation to buy or sell any particular security.